NICE
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
NICE guidelineNICE antenatal care guideline
A brief summary of NICE guidance on routine care for the healthy pregnant woman. Includes information, lifestyle advice, and foetal and maternal screening.
- NICE guideline
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.
- NICE guideline
NICE angina guideline
A brief summary of NICE's clinical guideline on the management of stable angina. Includes care pathway algorithm, counselling, and secondary prevention.
- NICE guideline
NICE primary joint replacement guideline
This summary covers the responsibilities of primary care providers for patients before they undergo a planned knee, hip or shoulder replacement
- NICE guideline
NICE epilepsy guideline
A brief, helpful summary of the diagnosis and management of epilepsy in adults and children. Includes status epilepticus management, review, and referral.
- NICE guideline
COVID-19 rapid guideline: children and young people who are immunocompromised
The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
- NICE guideline
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources
- NICE guideline
COVID-19 rapid guideline: dialysis service delivery
This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak
- NICE guideline
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
This useful summary covers diagnosis and initial management, outpatient treatment for low-risk pulmonary embolism, anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism, and information and support for people having anticoagulation treatment
- NICE guideline
COVID-19 rapid guideline: chronic kidney disease
This COVID-19 rapid guideline aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
- NICE guideline
COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
- NICE guideline
COVID-19 rapid guideline: managing COVID-19 symptoms in the community
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection
- NICE guideline
NICE CKS—teething
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
- NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
- NICE guideline
COVID-19 rapid guideline: pneumonia in adults
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic.
- NICE guideline
NICE sepsis guideline
This Guidelines summary covers recognition, diagnosis, and early management of sepsis for all populations. It should be used together with NICE's algorithms organised by age group and treatment location and the risk stratification tools. Please refer to the full guideline for a complete list of recommendations.
- NICE guideline
COVID-19 rapid guideline: cystic fibrosis
The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.
- NICE guideline
COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)
The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.
- NICE guideline
COVID-19 rapid guideline: severe asthma
The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.
- NICE guideline
COVID-19 rapid guideline: delivery of systemic anticancer treatments
This guideline aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic
